Rigel Pharmaceuticals (RIGL) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -130.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.61% |
| Dec 31, 2025 | -49.83% |
| Sep 30, 2025 | -72.95% |
| Jun 30, 2025 | -45.86% |
| Mar 31, 2025 | -35.11% |
| Dec 31, 2024 | -54.42% |
| Sep 30, 2024 | 27.77% |
| Jun 30, 2024 | 30.45% |
| Mar 31, 2024 | -65.36% |
| Dec 31, 2023 | -40.76% |
| Sep 30, 2023 | -27.24% |
| Jun 30, 2023 | 36.93% |
| Mar 31, 2023 | -68.33% |
| Dec 31, 2022 | 64.38% |
| Sep 30, 2022 | 234.90% |
| Jun 30, 2022 | 50.92% |
| Mar 31, 2022 | 184.75% |
| Dec 31, 2021 | 45.81% |
| Sep 30, 2021 | -68.69% |
| Jun 30, 2021 | -45.26% |
| Mar 31, 2021 | -31.29% |
| Dec 31, 2020 | 30.98% |
| Sep 30, 2020 | 37.20% |
| Jun 30, 2020 | -37.97% |
| Mar 31, 2020 | 448.56% |
| Dec 31, 2019 | -77.67% |
| Sep 30, 2019 | -26.58% |
| Jun 30, 2019 | -40.38% |
| Mar 31, 2019 | 45.89% |
| Dec 31, 2018 | -45.25% |
| Sep 30, 2018 | -19.72% |
| Jun 30, 2018 | -25.01% |
| Mar 31, 2018 | 34.65% |
| Dec 31, 2017 | -59.84% |
| Sep 30, 2017 | 1.16% |
| Jun 30, 2017 | -33.38% |
| Mar 31, 2017 | -26.29% |
| Dec 31, 2016 | -55.21% |
| Sep 30, 2016 | -11.33% |
| Jun 30, 2016 | 32.63% |
| Mar 31, 2016 | -31.28% |
| Dec 31, 2015 | 28.42% |
| Sep 30, 2015 | 17.11% |
| Jun 30, 2015 | -32.87% |
| Mar 31, 2015 | -28.65% |
| Dec 31, 2014 | -1.76% |
| Sep 30, 2014 | 38.13% |
| Jun 30, 2014 | 31.31% |
| Mar 31, 2014 | -34.83% |
| Dec 31, 2013 | 43.92% |
| Sep 30, 2013 | 18.89% |